ask="37.00"
ask_size="3000"
average_daily_volume="1308030"
bid="33.80"
bid_size="100"
book_value="5.75"
change="-1.30"
change_from_200_day_moving_average="16.93"
change_from_50_day_moving_average="12.94"
change_from_52_week_high="-1.65"
change_From_52_week_low="24.16"
change_in_percent="-3.45%"
close="36.40"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.25"
ebitda="-70.16M"
eps_estimate_current_year="-2.37"
eps_estimate_next_quarter="-0.66"
eps_estimate_next_year="-3.13"
ex_dividend_date="N/A"
float_shares="26842000"
high="37.30"
high_52_weeks="38.05"
last_trade_date="3/14/2017"
last_trade_price="36.40"
last_trade_size="20185"
last_trade_time="4:00pm"
low="35.25"
low_52_weeks="12.24"
market_capitalization="1.36B"
moving_average_200_day="19.47"
moving_average_50_day="23.46"
name="Global Blood Therapeutics
Inc."
notes="N/A"
one_year_target_price="48.17"
open="37.20"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+87.00%"
percent_change_from_50_day_moving_average="+55.17%"
percent_change_from_52_week_high="-4.34%"
percent_change_from_52_week_low="+197.39%"
previous_close="37.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.55"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37316000"
short_ratio="7.75"
stock_exchange="NMS"
symbol="GBT"
volume="1516262"
weeks_range_52="12.24 - 38.05"
